GRCE
Grace TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
GRCE vs peer average
81/100
GRCE vs. peer average (B vs. D)
Grade spread
B 3 · D 3 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ALGS is the first available peer comparator.
Same-sector, similar-market-cap comparator; the packet provides no direct therapeutic overlap, so valuation use is weak.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
GRCE
Grace Therapeutics
ALGS
Aligos Therapeutics
Grade
B
D
Momentum
70
65
Value
41
41
Sentiment
75
47
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs ALGS
GRCE / ALGS
Grade Position
Above peers
GRCE vs. peer average (B vs. D)
81/100
Momentum
70
GRCEValue
41
GRCESentiment
75
GRCERotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs GRCE
ALGS is the first peer returned for this comparison set.